baber/WOPTO huggingface dataset:
Patent NZ-570461-A (NZ)
Title: Plasma coated fabrics, clothing, clothing accessories, textiles or footwear
Inventor: COULSON STEPHEN
IPC: B29C59/14
Filed: 2007-01-19
Abstract: Disclosed is an item selected from: (a) footwear; or (b) a piece of fashion or sports clothing, a clothing accessory, or a household textile, comprising a fabric selected from silks, satins, wool, wool blends, leather and suede, linen, or a fine synthetic fabric; having a polymeric coating formed by exposing said item or a material or yarn from which the item is constructed, to a pulsed plasma comprising a compound of formula (I), where R1, R2 and R3 are independently selected from hydrogen, alkyl, haloalkyl or aryl optionally substituted by halo; and R4 is a group X-R5 where R5 is an alkyl or haloalkyl group and X is a bond; a group of formula -C(O)O-, -C(O)O(CH2)nY- where n is an integer of from 1 to 10 and Y is a bond or a sulphonamide group; or a group -(O)pR6(O)q(CH2)t- where R6 is aryl optionally substituted by halo, p is 0 or 1, q is 0 or 1 and t is 0 or an integer of from 1 to 10, provided that where q is 1, t is other than 0, for a sufficient period of time to allow a protective polymeric layer to form on the surface of the item, material or yarn. Items of this type are protected from contamination by a wide number of liquids, including environmental hazards such as rain water and water based liquids as well as some oily liquids. They are also fade and odour resistant and are suitable for enhancing colour fastness of such fabric and articles made from them.
Patent NZ-575308-A (NZ)
Title: Composition featuring enhanced adhesion to porous substrates
Inventor: TEYSSEIRE RAPHAEL
IPC: C09J163/00
Filed: 2009-03-04
Abstract: Disclosed herein is a composition which comprises at least one silane functional polymer, at least one organosilane comprising at least one sulfur atom, and at least one organotitanate. Also disclosed is (1) a process for adhesively bonding or adhering two substrates S1 and S2, comprising: applying the composition on the substrates S1 and/or S2; contacting the substrates S1 and S2 on the applied composition within the open time of the composition; and hardening (curing) the composition by water, preferably in the form of humidity or atmospheric moisture, where the substrates S1 and S2 are same or different from one another; and (2) a process for sealing or coating the substrates S1 and S2, comprising: applying the composition on the substrates S1 and/or S2; and hardening (curing) the composition by water, preferably in the form of humidity, where the substrates S1 and S2 are same or different from one another.
Patent NZ-578307-A (NZ)
Title: Lightweight geopolymer and method for preparing
Inventor: BOLT CLIVE JOHN
IPC: C01B33/26
Filed: 2009-07-09
Abstract: Disclosed is a method for producing a lightweight inorganic polymer material that includes the following steps in order: A. prepare activator solution; B. add activator solution to a metakaolin and mix; C. add a finely divided form of aluminium and a calcium additive then mix; where the activator solution is made by combining a group 1 metal soluble silicate solution with a group 1 metal hydroxide until the hydroxide concentration is between 3.5 and 10.5 molar, such that the mixing of the activator solution and metakaolin forms an Inorganic Polymer Matrix (IPM) paste, such that the calcium additive is at least food grade with a low magnesium (less than about 2%) content.
Patent NZ-580465-A (NZ)
Title: A spacer that limits compression of an insulator
Inventor: ROACH JOHN ROBERT
IPC: E04B1/62
Filed: 2008-04-18
Abstract: A spacer (100) for providing space between a first roof member (110) and a second roof member (120), where the spacer limits compression of an insulator (130), the insulator being at least partially between the first roof member and the second roof member.
Patent NZ-584754-A (NZ)
Title: Fungicidal composition and method for controlling noxious fungi
Inventor: MITANI SHIGERU
IPC: A01N35/04
Filed: 2008-10-20
Abstract: Disclosed is a fungicidal composition comprising a carboxylic acid amide of formula (I), which is N-[(3',4'-dichloro-1,1-dimethyl)phenacyl]-3-methyl-2-thiophenecarboxamide, N-[[2'-methyl-4'-(2-propyloxy)-1,1-dimethyl]phenacyl]-3-trifluoromethy1-2-pyridinecarboxamide, N-[[2'-methyl-4'-(2-propyloxy)-1,1-dimethyl]phenacyl]-3-methyl-2-thiophenecarboxamide, N-[[4'-(2-propyloxy)-1,1-dimethyl]phenacyl]-3-trifluoromethy1-2-pyridinecarboxamide, N-[[4'-(2-propyloxy)-1,1-dimethyl]phenacyl]-3-methyl-2-thiophenecarboxamide and N-[[4'-(2-pentyloxy)-1,1-dimethyl]phenacyl]-3-trifluoromethy1-2-pyridinecarboxamide And a fungicidal compound selected from: triflumizole, myclobutanil, cyproconazole, tebuconazole, hexaconazole, N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide, metconazole, epoxiconazole, prothioconazole, difenoconazole, tetraconazole, tricyclazole, oxpoconazole fumarate, cyazofamid, hymexazol, mepanipyrim, pyrimethanil, cyprodinil, ferimzone, 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine, azoxystrobin, kresoximmethyl, trifloxystrobin, dimoxystrobin, pyraclostrobin, captan, folpet, fluazinam, potassium bicarbonate, sulfur, mancozeb, chlorothalonil, procymidone, iprodione, spiroxamine, fludioxonil, metrafenone, fenpropidin, meptyldinocap, dimethomorph, fenpropimorph, cymoxanil, potassium phosphite, fosetyl-Al, tolclofos -methyl, flutolanil, fenhexamid, quinoxyfen, copper oxychloride, thiophanate-methyl, pyribencarb, propamocarb hydrochloride, polyoxins, kasugamycin, iminoctadine, cyflufenamid, 2,3-dimethyl-6-t-butyl-8-fluoro-4-acetylquinoline, 2-(2-fluoro-5-(trifluoromethyl)phenylthio)-2-(3-(2- thoxyphenyl)thiazolidin-2-yliden)acetonitrile, proquinazid, 4-(2,3,4-trimethoxy-6-methylbenzoyl)-2,5-dichloro-3-trifluoromethylpyridine, 4-(2,3,4-trimethoxy-6-methylbenzoyl)-2-chloro-3-trifluoromethyl-5-methoxypyridine, 3-(2,3,4-trimethoxy-6-methylbenzoyl)-5-bromo-4-chloro-2-methoxypyridine and 3-(2,3,4-trimethoxy-6-methylbenzoyl)-5-chloro-2-methoxy-4-methylpyridine.
Patent NZ-589293-A (NZ)
Title: Antiallergic marine biopolymers comprising iota-carrageenan
Inventor: GRASSAUER ANDREAS
IPC: A61K31/731
Filed: 2009-06-30
Abstract: Disclosed is the use of a pharmaceutical composition comprising iota-carrageenan for the prevention or treatment of allergic rhinitis, allergic conjunctivitis, or allergic asthma. The pharmaceutical composition is formulated for administration to mucosal surfaces of the respiratory tract or the eyes. The composition is substantially free of lambda-carrageenan.
Patent NZ-590628-A (NZ)
Title: Hiv vaccine based on targeting maximized gag and nef to dendritic cells
Inventor: BANCHEREAU JACQUES F
IPC: A61K39/12
Filed: 2009-07-16
Abstract: A dendritic cell (DC)-specific antibody to which an engineered Gag antigen is attached via a flexible linker. The gag antigen is less susceptible to proteolytic degradation by eliminating one or more proteolytic sites. The antibody is used for making vaccines and in methods to increase the effectiveness of antigen presentation by an antigen presenting cell.
Patent NZ-591526-A (NZ)
Title: Solar thermal power generation using first and second working fluids which are independently variable or of different temperature in a rankine cycle
Inventor: LEIBOWITZ HERMAN
IPC: F01K23/04
Filed: 2009-08-19
Abstract: 591526 A system to convert the heat collected by solar thermal collectors into electricity using a Rankine cycle generator with multiple working fluids and multiple temperature-level heat sources is disclosed. First and second thermal transfer fluids are used to heat a working fluid in one or more power generation cycles. The first and second thermal transfer fluids are independently variable or of different temperature.
Patent NZ-592518-A (NZ)
Title: Liner for a shipping container releasably attached to lashing points inside the container
Inventor: MCANDREW ALEC
IPC: B65D88/54
Filed: 2009-07-15
Abstract: A liner for a shipping container is disclosed. The liner comprises a roof panel (28), two side wall panels (26) extending downward from the roof panel and an end wall panel (30). Cords (24) are anchored (38) to the liner adjacent the end wall panel (30). Loops are disposed at intervals along the length of the liner near where the side wall panels (36) intersect the roof panel (28) and the cords (24) pass through the loops. The cords have hooks that are attachable to lashing points along the container. The liner has means for temporarily tensioning the cords (24) to pull the top edges of the sidewall panels (26) up towards the lashing points.
Patent NZ-594118-A (NZ)
Title: A dry powder composition for preventing or treating influenza comprising a lactose hydrate diluent and (2R,3R,4S)-3-acetamido-4-guanidino-2-[(1R,2R)-2-hydroxy-1-methoxy-3-(octanoyloxy)propyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
Inventor: MIYAJIMA MAKOTO
IPC: A61K31/351
Filed: 2009-12-24
Abstract: Disclosed is a dry powder pharmaceutical composition suitable for inhalation comprising (2R,3R,4S)-3-acetamido-4-guanidino-2-[(1R,2R)-2-hydroxy-1-methoxy-3-(octanoyloxy)propyl]-3,4-dihydro-2H-pyran-6-carboxylic acid (Formula (I)), and optionally (2R,3R,4S)-3-acetamido-4-guanidino-2-[(1S,2R)-3-hydroxy-1-methoxy-2-(octanoyloxy)propyl]-3,4-dihydro-2H-pyran-6-carboxylic acid (Formula (II)) with a lactose hydrate diluting agent, wherein the lactose hydrate has a particle distribution satisfying one of (Condition-1): the particle size distribution of the lactose hydrate measured by particle size analysis-laser diffraction methods has a 10 per cent by weight particle size of 5 microns to 60 microns, a 50 per cent by weight particle size of 50 microns to 110 microns, and a 90 per cent by weight particle size of 75 microns to 160 microns or (Condition-2): in the particle size distribution measured by an air entrainment method, a fraction with a particle size of less than 32 microns, a fraction with a particle size of less than 63 microns, a fraction with a particle size of less than 100 microns make up 5 to 10 per cent by weight, 70 to 100 per cent by weight, and100 per cent by weight, respectively; and another lactose hydrate having a particle size distribution satisfying one of (Condition-3): the particle size distribution of the lactose hydrate measured by particle size analysis-laser diffraction methods has a 10 per cent by weight particle size of 3 microns or less, a 50 per cent by weight particle size of 20 microns or less, and a 90 per cent by weight particle size of 54 microns or less or (Condition-4): in the particle size distribution measured by an air entrainment method, a fraction with a particle size of less than 45 microns, a fraction with a particle size of less than 63 microns, and a fraction with a particle size of less than 150 microns make up 90 to 100% by weight, 98 to 100 per cent by weight, and 100 per cent by weight, respectively.
Patent NZ-596455-A (NZ)
Title: Smoking article where a window allows view of filter tip
Inventor: SUTTON JOSPEH PETER
IPC: A24C5/47
Filed: 2010-05-05
Abstract: A smoking article (10) comprises a rod (12) of smokeable material and a filter (14) attached to one end of the rod. The filter comprises an elongate body of filter material (16) wrapped with a transparent plug wrap (18). A first tipping wrapper (20a) overlies the join between the rod and the filter to attach the filter to the rod. At least one additional tipping wrapper (20b) is provided around the filter, spaced from and separate to the first tipping wrapper such that a portion of the transparent plug wrap is exposed between the first and at least one additional tipping wrapper to define a window portion (22) through which the filter material is visible. A method of producing such a smoking article is also disclosed.
Patent NZ-596560-A (NZ)
Title: Compositions for use in security marking
Inventor: BROWN JASON
IPC: C12Q1/68
Filed: 2010-04-23
Abstract: 596560 Discloses a security marking composition comprising: A plurality of identical first synthetic nucleotide oligomers A plurality of second synthetic nucleotide oligomers which are different from the first, Wherein, the first nucleotide oligomers comprise a first primer binding site, second primer binding site and a first identifier sequence of 3-7 bases in length which is between the first and second primer sites. Wherein, the second nucleotide oligomers comprise a third primer binding site, fourth primer binding site and a second identifier sequence of 3-7 bases in length which is between the first and second primer sites. Wherein the first identifier sequence is different from the second And wherein the owner of the composition is identifiable from the identifier sequences using a database.
Patent NZ-596580-A (NZ)
Title: Method to clean a moistened soiled substrate without organic solvents
Inventor: JENKINS STEPHEN DEREK
IPC: D06L1/01
Filed: 2010-05-10
Abstract: IP No. 596580 The disclosure relates to a method for cleaning a soiled substrate, said method comprising a batchwise process for the treatment of the moistened substrate with a formulation comprising a solid particulate cleaning material wherein said formulation is free of organic solvents and said solid particulate cleaning material comprises a multiplicity of polymeric particles, said treatment comprising agitation of said substrate and said formulation in at least one sealed container, wherein said container provides an ullage value of from 30-60% by volume, and wherein said polymeric particles are re-used in further cleaning procedures according to the method. Preferably the sealed container comprises a metal container or a container formed from a rigid or flexible plastic material. Preferably, the substrate is wetted. Preferably the solid particulate cleaning material comprises a multiplicity of polymeric particles which comprise at least one additional cleaning agent such as a surfactant. Preferably, the substrate comprises a textile fibre. Typically, the polymeric particles comprise particles of nylon or polyester.
Patent NZ-596936-A (NZ)
Title: Devices, a computer program product and a method for data extraction
Inventor: SOLEM KRISTIAN
IPC: A61B5/02
Filed: 2010-06-24
Abstract: 596936 Disclosed is an extracorporeal fluid system (20). The system (20) includes a device for processing a measurement signal obtained by a pressure sensor (4a) in the system (20) when the system (20) is connected to a vascular system of a subject. The device includes means (25) for receiving the measurement signal and means (23) for processing the measurement signal for identification of pressure data. The data includes information relating to at least one pulse, originating from a physiological phenomenon in the subject such that the physiological phenomenon does not include the heart of the subject.
Patent NZ-603425-A (NZ)
Title: System for collaborative transactions
Inventor: RICHARDSON RIC B
IPC: G06Q30/00
Filed: 2011-04-12
Abstract: Disclosed is a device which enables collaborative contributions for the purchase of goods or services. The device includes an input device, an output device and a communication interface all in communication with a processor and memory. The device is in communication with a database. The device is adapted to receive input from one or more users and permits the users individually and separately to make a contribution in a predetermined amount towards a designated target contribution amount. The device implements a ticketing system whereby a predetermined number of tickets are made available for distribution for a specified transaction for a predetermined period of time whereby the transaction must be completed by no later than the predetermined period of time. The predetermined number, the predetermined time and a transaction result are publicised. Tf the tickets are all distributed by the predetermined time or earlier then one ticket is randomly selected and the entity associated with that ticket is awarded the benefit of the transaction.
Patent NZ-615154-A (NZ)
Title: Micro-organism threat detection
Inventor: SHARPIN ROSEMARY KATHERINE CAMERON
IPC: G01N33/00
Filed: 2011-06-22
Abstract: Disclosed is a method of cumulating and displaying the results of analysis for specific micro-organisms within a physical area. The method is performed by providing within the area multiple micro-organism analysis units (108-117), culturing samples from known locations within the physical area in micro-organism analysis units (108-117), providing, remote from the physical area, a central location capable of receiving results from analysis units (108-117). The method also includes receiving at the central location the results of analyses from the analysis units (108-117) and the location of the analysis samples and displaying the results on a micro-organism count versus time basis on a map of the physical area. A time/count reversion is then used to identify a sub-area of the area as the tentative origin of the increase in micro-organisms. The analysis units (108-117) may then be relocated to locations within the identified sub-area and the method repeated until the tentative origin is confirmed.
Patent NZ-625695-A (NZ)
Title: Therapeutic neuromodulation of the hepatic system
Inventor: AZAMIAN BOBAK ROBERT
IPC: A61N1/28
Filed: 2012-12-07
Abstract: Disclosed is a system adapted for intravascular hepatic neuromodulation. The system includes an energy source adapted to deliver energy, and an ablation device which is sufficiently flexible so as to facilitate access to and positioning within a hepatic artery in a subject. The ablation device has a proximal end and a distal end, the distal end comprising one or more electrodes or transducers. The system also includes one or more electrically conductive wires connecting the energy source to the one or more electrodes or transducers. The system is adapted to deliver a therapeutically effective amount of energy to disrupt communication along one or more nerves surrounding the hepatic artery.
Patent NZ-628101-A (NZ)
Title: Tube support
Inventor: GEOFFREY BRYAN MACKNEY
IPC: A62B35/00
Filed: 2014-07-07
Abstract: Disclosed is a support (100) in the form of a harness for supporting a portion of a feeding tube. The disclosure notes that typically adhesive tape is used to secure a free end of a feeding tube which is surgically embedded in patient. Adhesive tape can cause tearing and irritation to a patients skin. The support (100) includes a torso embracing portion (10) and two or more tube holding portions. The torso embracing portion (10) embraces a torso of the patient. The two or more tube holding portions hold the tube and are fixable to, or part of, the torso embracing portion (10). The two or more tube holding portions are positioned to be spaced across the patient’s chest to embrace the tube at differing locations to accommodate variation in the location and the orientation at which the tube is at least partly embedded.
Patent NZ-630561-A (NZ)
Title: Marine lifting vessel
Inventor: NORMAN CLIFFORD SMITH
IPC: E02B15/00
Filed: 2013-09-10
Abstract: A marine lifting vessel or catamaran having two buoyant hulls each provided with static buoyancy, where the catamaran has a rigid working deck 130 having a top, an underneath, two sides, a bow aspect and a stern aspect. The deck 130 is movably and symmetrically supported along each side from the adjacent hull by a plurality of intermediate beams arranged in a parallel array thereby indirectly securing one hull to the other. Each intermediate beam is comprised of two beams ( a “hull beam” and a “deck beam”), pivotally joined together at their adjacent ends and having a substantially horizontal axis of rotation, thereby forming a lifting joint, the far end of each beam being fixedly attached to the hull and to the deck 130 respectively. Each joint shares a common axis of rotation with the joints of the other intermediate beams. The catamaran includes joint control or actuator means to forcibly change the angle between the hull beam and the deck beam at the lifting joint. All joint control means are under the co-ordinated control of a controller, so that, when in use, a height of the rigid deck 130 in relation to a water line can be altered by the controller by forcibly causing the angles of a plurality of the joints to change thereby either lifting the deck 130 higher above the water line, or lowering the deck 130 to or below the water line.
Patent NZ-707591-A (NZ)
Title: Modified antibodies and method for the production of same
Inventor: DAVID GEARING
IPC: C12N15/13
Filed: 2012-09-05
Abstract: Disclosed is a neutralising antibody or an antigen binding fragment thereof which is capable of specifically binding to human nerve growth factor (NGF) wherein the antibody or antigen binding fragment comprises a light chain variable region comprising the amino acid sequence of SEQ ID NO:13 or an amino acid sequence which has an identity of at least 90% thereto and a heavy chain variable region comprising the amino acid sequence of SEQ ID NO:14 or an amino acid sequence which has an identity of at least 90% thereto, wherein the antibody or an antigen binding fragment thereof does not contain any amino acid in any position within the framework regions of the heavy and light chain variable domains which would be foreign at that position in one or more immunoglobulins derived from a human.
Patent NZ-711761-A (NZ)
Title: Compositions and methods of enhancing immune responses to enteric pathogens
Inventor: HARGIS BILLY
IPC: A61K35/74
Filed: 2014-03-14
Abstract: Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide, e.g., EGHADERGTPEYNISLGER. The PAL polypeptide may be expressed on the surface of the vaccine vector. The vaccine vector may also include a second polypeptide encoding an immunostimulatory polypeptide such as a CD 154 polypeptide or an HMGB1 polypeptide.
Patent NZ-718882-A (NZ)
Title: Measurement method and measurement circuit for power parameter
Inventor: TAN YUE
IPC: G01R21/06
Filed: 2014-10-09
Abstract: Disclosed are a measurement method and measurement circuit for a power parameter. The measurement method comprises: adjusting the size of conduction angles, and acquiring a maximum voltage waveform value of a live line end or a load end at different conduction angles; dividing the maximum voltage waveform value at different conduction angles by a standard maximum waveform value of a corresponding conduction angle acquired at a standard voltage to obtain a voltage ratio at different conduction angles; according to the voltage ratio, acquiring voltage effective values and active power at different conduction angles; according to the voltage effective values and current effective values at different conduction angles, acquiring apparent power at different conduction angles; and finally, controlling the current effective values, the voltage effective values, the active power and the apparent power to display for user reference. Power parameters can be calibrated according to voltage ratios obtained at different conduction angles, and power parameters can be accurately acquired. Moreover, a user can directly observe real-time power parameters, thereby being convenient for a user to use.